Tagged / collaboration

NIHR Research Design Service – Starting Research Workshop

Please see below for the following training opportunity:

Date: 15 September 2021
Time: 09:15-13:30
Location: Online

Funded and hosted by the NIHR Research Design Service (RDS) South Central, discover how to move from thinking about doing research to taking your first steps in the getting support, dedicated time and funding to actually do it. Sign up to the workshop on Eventbrite.

Health Research Authority’s new student research eligibility criteria – live from today

New eligibility criteria for standalone student research go live today (1 September 2021). These changes are designed to ensure that students’ experience of research reflects how modern health and social care research is conducted.

This new criteria encourages innovative approaches to student research like group research, mock Research Ethics Committees (REC) or shadowing a range of people in an existing project.

The changes mean some master’s students will now be eligible to apply for approval to carry out their research.

To help students plan their research we have created a new student research toolkit. The toolkit has been designed to pull together the resources a student will need to understand what approvals are required and whether they are eligible to carry out their research in the UK.  It contains links to existing decision tools as well as some new ones developed especially for students. It uses a simple question and answer format and will provide answers to the following questions:

  • Is my study research?
  • Is my research taking place in the NHS and will it need NHS approval?
  • Do I need NHS REC review?
  • What type of NHS ethics review do I need?
  • Can I carry out my research?

Completing the tool will provide students with an understanding of what activities they can do and ensures that they do not waste time applying for approval for research that they are not able to carry out under the new student eligibility criteria. Through completion of the toolkit, students can access supplementary declarations that need to be completed by their academic supervisor, confirming that they meet the criteria for the type of approvals they need for their research. There are three separate declarations depending on the approvals needed – the toolkit guides the student to the right one based on their responses.

Please share this update and new resource with colleagues and students who might benefit. Further details about the new eligibility criteria can be found on the HRA website.

Please see our question and answer section for further information. If you have any other queries about the eligibility criteria, please contact queries@hra.nhs.uk.

Please contact Suzy Wignall, Clinical Governance Advisor in RDS if you have any queries or concerns.

Health Research Authority Releases Question and Answers: Student Eligibility Criteria

The Health Research Authority have published some questions and answers in relation to student research – this is in relation to the recent update regarding the upcoming changes to eligibility criteria.

You can find the Q&As here.

If you have any queries please contact Suzy Wignall, Clinical Governance Advisor in Research Development & Support.

BU conference presentation on migration and COVID-19 in Nepal

Yesterday Dr. Pramod Regmi, Dr. Shovita Dhakal Adhikari, Dr. Nirmal Aryal and Prof. Edwin van Teijlingen, all based in the Faculty of Health & Social Sciences, presented at the tenth Annual Kathmandu Conference on Nepal & the Himalaya.  Their paper ‘Moral panic and othering practices during Nepal’s COVID-19 Pandemic (A study with returnee migrants and Muslims in Nepal)’ was co-authored by Dr. Sharada Prasad Wasti from the University of Huddersfield and Shreeman Sharma (Department of  Conflict, Peace & Development
Studies, Tribhuvan University, Nepal).  The presentation was partly based on research funded by the British Academy.

 

Funding Development Briefings – back in September

The RDS Funding Development Briefings have occurred weekly, on a Wednesday at 12 noon since January 2021.

Thank you to those of you who have joined us to discuss the latest funding opportunities, ask questions, and share your research ideas. We will be taking a break over August, with the briefings returning in September.

Over August, we will still update the Major Opportunities pipeline on a weekly basis so you have access to the latest funding opportunities. The pipeline is available on the I Drive here: I:\RDS\Public\Funding Pipeline. The Research Facilitators will still be available over the summer to discuss your research bidding plans, so please do get in touch when required.

Details of the Funding Development Briefings for 2021/22 will be available shortly. Please email RKEDF@bournemouth.ac.uk to receive the Teams invite for these sessions.

We hope you have a restful summer, and look forward to seeing you in September!

New FHSS nutrition publication

Congratulations to Faculty of Health & Social Sciences’ PhD student Karim Khaled and supervisors Prof. Vanora Hundley and Dr. Fotini Tsofliou on the acceptance of your manuscript ‘Perceived Stress was associated with Poorer Diet Quality among Women of Reproductive Age in the UK’.  This paper will appear in the international journal Nutrients.
All three are associated with our research unit CMMPH (Centre for Midwifery, Maternal & Perinatal Health). This paper is supported by BU’s Open Access Fund will be freely available online soon.

Well done!

 

Prof. Edwin van Teijlingen

CMMPH

New joint publication with  Dorset HealthCare University NHS Foundation Trust

 

This morning International Journal of Mental Health Nursing informed us that our article  ‘Cultural issues on accessing mental health services in Nepali and Iranian migrants communities in the UK‘ has been published today.   This paper is written by an interdisciplinary team including Hannah Blunt who works at Dorset HealthCare University NHS Foundation Trust, Dr. Bibha Simkhada who is Senior Lecturer in Nursing at the University of Huddersfield and Dr. Mariam Vahdaninia who works in the Peninsula Medical School at the University of Plymouth.  Both Mariam and Bibha worked with me at Bournemouth University at the time of the study.

Prof. Edwin van Teijlingen

CMMPH (Centre for Midwifery, Maternal & Perinatal Health)

Health Research Authority UPDATE: undergraduate and master’s research projects

New eligibility criteria from 1 September 2021

The HRA and the devolved administrations, supported by the Wessex Institute at the University of Southampton, have reviewed their approach to study approval for student research.

The review aimed to ensure students have the best learning experience of health and social care research, and to reduce the time that the HRA, DAs and NHS Research Ethics Committees (RECs) spend advising on and reviewing student applications.

In March 2020 the HRA paused student research approvals to create capacity for urgent COVID-19 research. Now, from 1 September 2021, they are introducing new eligibility criteria for standalone student research.

The new criteria mean that some master’s level students will be able to apply for ethics review and HRA/HCRW Approval or devolved administration equivalent. Standalone research at undergraduate level that requires ethics review and/or HRA/HCRW Approval (or devolved administration equivalent) cannot take place. Arrangements for doctoral research remain unchanged. Full details are in table one – permitted student research table. They have also made it clear when students are able to take the role of Chief Investigator, see table two – which type of students may act as Chief Investigator.

It is possible for students to learn about health and social care research without completing standalone projects. Looking at other ways to build skills and experience better reflects modern research and emphasises team science. View the video of the HRA event ‘Exploring good practice in Student Research’ to hear from course leaders about how successful these alternative approaches have been (registration is required to view) or read the HRA website for further information and ideas https://www.hra.nhs.uk/student-research/.

The HRA are giving notice now so that course leaders and students have time to prepare for the new arrangements, including ensuring that any changes to institutional policies and procedures are made.

If you have any queries about the eligibility criteria, please contact queries@hra.nhs.uk or swignall@bournemouth.ac.uk

Invitation to the Medical Science Virtual STEAMLab 2021

On Thursday 22nd July 2021 from 2-4pm, RDS will be hosting a virtual STEAMLab event under the strategic investment area (SIA) of Medical Science. It will be the third of a series to 2-hour long virtual STEAMLabs to be held in the course of 2021.

The ideas generated at this event may also be used to help select colleagues for further Scramble events at short notice.

Booking onto this event

To take part in this exciting opportunity, we ask all participants to download and complete the Application Form and return this to Lisa Andrews by Monday 14th June.

By applying, you agree to attend for the full duration of the event on 22nd July from 2pm – 4pm. Places at the event are limited and you will be contacted to confirm your “virtual space” by 21st June 2021

If you have any queries prior to submitting your application, please contact RDS Research Facilitators Lisa Andrews or Ehren Milner.

The Brief

We’re seeking to come up with highly innovative and urgently required research which is ambitious in scope and will require a high level of expertise, commitment and funding. The research must address challenges in the field of Medical Science.

In short, we anticipate the development of innovative, ground-breaking cross-disciplinary and ambitious projects which have the capacity to attract significant, high value external funding from the public and private sectors in the future.

We would also like to use this opportunity to further collaborations with our local clinical colleagues, and are delighted to be welcoming a number of attendees from local NHS Trusts to join us at this event.

Who should attend?

We welcome those who wish to contribute to having a positive impact through addressing scientific challenges, but in particular, we are specifically targeting the following:

  1. Those academics whose research aligns with one or more of the BU’s core research areas, or whose research would benefit from the multidisciplinary, collaborative engagement supported by the Medical Science SIA;
  2. Those who have experience of involvement in medium to large scale research projects.

Some Answers to your FAQs:

Do I need to do anything in advance?

During the STEAMLab, you’ll be guided through a process which results in the development of collaborative research ideas. To aid us in this process, we will be using the platform Padlet to discuss and share ideas on a number of research themes ahead of the event. This will enable us to identify the themes of the day by asking you as the attendees to contribute your thoughts and ideas ahead of the STEAMLab.

What is the immediate objective?

The objective by the end of the STEAMLab is to have scoped some leading and grand ideas around which a working group or cluster can be formed to take forward towards the development of a large grant application. This event is run to facilitate new interdisciplinary research collaborations.

What do I need to do afterwards?

Your project idea may be “oven-ready”, but it is more likely that you/your group’s project idea/s will require some time to crystallise fully, and for the optimum partners to be found for the building a winning consortium. To this end, it is envisaged that you and your potential collaborators will be committed to meeting on a regular basis, with a firm timetable.

What if my topic area is very specialised, within fields such as medical diagnostics or environmental science?

Your contribution will be very welcome! One of the main benefits of a STEAMLab event is to bring together individuals with a range of backgrounds and specialisms who are able to see things just that bit differently to one another.

HEIF Proof of Concept Strand: Open for Applications

HEIF Proof of Concept Strand: Open for Applications

BU actively supports staff turning their research into technology opportunities or businesses and is offering awards of a maximum of £5,000. The principal objective of the Proof of Concept Strand is to accelerate the BU research pathway, supporting the maturation of innovations towards commercial exploitation.

This funding is designed to progress BU research projects such that the individual project can attract further funding and/or provide support to expedite the exploitation of the target opportunity.

Eligibility

The HEIF Proof of Concept Strand is open to academic staff across BU.

Due to the nature of this fund, we particularly welcome applications from the following:

  • Early Career Researchers (ECRs)
  • Proposals that incorporate social sciences and humanities
  • Proposal that demonstrate interdisciplinarity research approaches and/or include collaborations with other departments.

In line with BU2025, we will positively encourage applications from under-represented groups.

What we can and cannot fund

The HEIF Proof of Concept Strand will only support development of innovations that have arisen from BU research.

Funding will be available to support activities including but not limited to the following:

  • Key translational activities that cannot proceed with current funding such as prototyping, specific market research, accreditation attainment, IP protection, IP strategy/landscaping, equipment purchases, demonstration events for marketing and connection to later stage investment.
  • Development of the project such that it addresses a specific barrier that is preventing the attainment of translational funds or will run in parallel to existing translational funds, adding value to the overall development of the project.
  • Further develop existing technology/acquire new data to identify other routes for exploitation or obtain additional data or information to determine a specific capacity.
  • General early market assessment activities to value the innovation/technology position and determine the most optimal routes for exploitation.
  • Focussed market assessment to provide guidance on how to refine the position of an innovation/technology.

Application Process

Please read the following documents before completing the application form:

All applicants are also advised to familiarise themselves with BU2025 strategy as part of the application process.

Applications must be submitted to heif@bournemouth.ac.uk.

The HEIF panel will assess all applications received. Applications are initially subject to a pre-screen check. Applications that pass the pre-screen will be forwarded to the HEIF Funding panel to review. Following the panel assessment process, the HEIF Funding panel will make recommendations for funding to RPMC. RPMC will review these recommendations, check alignment with internal/external strategies and make final decisions.

PoC Strand Closing Date

Applications will be regularly evaluated by the HEIF Panel until 16 June 2021, provided funds remain available until that date.

BU’s Funding Panels and Research Principles

The following funding panels operate to prioritise applications for funding and make recommendations to the Research Performance and Management Committee (RPMC).

There are eight funding panels:

  1. HEIF Funding Panel
  2. GCRF Funding Panel
  3. Research Impact Funding Panel
  4. Doctoral Studentship Funding Panel
  5. ACORN Funding Panel
  6. Research Fellowships Funding Panel
  7. Charity Impact Funding Panel
  8. SIA Funding panel.

These panels align with the BU2025 focus on research, including BU’s Research Principles.

The following BU2025 Principles are most relevant to the HEIF Panel:

  • Principle 1 – which recognises the need to develop teams
  • Principle 5 – which sets of the context for such funding panels

If you have any questions about your application, the process or requirements, then please email heif@bournemouth.ac.uk.

UK and Chinese experts work for the health benefits of patients

International experts in the economics of health care have gathered to explore the cost-effectiveness of using screening and diagnostics tools for the benefit of patients in the UK and China.

A masterclass was held at Zhejiang University on the 23rd and 24th March 2021, which explored the key economic arguments surrounding the implementation of diagnostic tools and screening programmes with practical examples of screening for lung cancer illustrating the talks. Presentations were given by Gill Caldicott, Area Director of British Council East China (inset) and leading experts in diagnostic and screening evaluation methodologies. The sessions were chaired by the UK-CHEP Partnership Leads, Professors Hengjin Dong (Zhejiang University) and Chris Bojke (University of Leeds).

UK-CHEP supports participating universities so they can work together to create significant impact for both the British and Chinese people and economy by engaging in long-term projects and knowledge collaborations that generate new expertise in health economics and health policy

UK-CHEP Is designed to:

  • Help build mutual understanding and deepen and broaden collaboration between participating universities by sharing research and educational opportunities that help deliver the goals of China’s “Double First Class” programme.
  • Promote international collaboration between world-class academics in China and the UK uninterrupted by the COVID-19 pandemic.

Professor Darrin Baines, Bournemouth University, said: “This masterclass demonstrates the ongoing commitment of our partners in China and the UK to work in partnership to help secure significant health and economic impact by improving patient quality of life through better and faster access to cost-effective medicines and promoting world-class research and education in keeping with China’s ‘Double First Class’ programme.”

Professor Chris Bojke (University of Leeds), Professor in Economic Evaluation and Health Technology Assessment Methods, said: “I am delighted that in conjunction with our partner university we have been able to come together in these challenging times to deliver a masterclass on the health economics of diagnostic testing and screening at Zhejiang University and online. I am confident that this partnership between universities, will mark the start of lasting research and teaching collaborations.”  Professor Bojke also acknowledged and thanked GSK for their contributions to the partnership.

Professor Hengjin Dong (Zhejiang University, pictured below), Professor in Health Policy and Health Economics said: “Zhejiang University and Leeds University, alongside Bournemouth University, have overcome the Covid-19 pandemic to work together to deliver this on-line and off-line masterclass programme focusing on the health economics of diagnostic tests and screening. This is a great trial.

“This cooperative work and programme will further strengthen the collaboration between UK and Chinese universities in the areas of health and health economics, especially in the areas of exchanging ideas and experience in the studies of health technology assessment and their application on the health policies. I believe this work will also contribute to the overall collaboration in the areas of health and economic development between our universities.”

The UK-China Health and Economy Partnership (UK-CHEP) promotes long-term collaboration in health economics and Health Technology Assessment for the mutual benefit of leading academic institutions in the UK and China, which has been funded by GlaxoSmithKline (GSK) and is overseen by the British Council.

This partnership promotes long-term collaboration in health economics and Health Technology Assessment (HTA) between four UK universities, Bournemouth University, University of Leeds, University of Sheffield, University of York, and three Chinese universities, Zhejiang University, Fudan University and Shandong University.

This partnership, led by Bournemouth University, was originally launched in Jinan, Shandong province in November 2017 by GSK.